Glenmark Pharmaceuticals GLIPIQ: Proven Weekly Treatment Starts at ₹325
Glenmark Pharmaceuticals GLIPIQ offers a proven weekly treatment starting at ₹325, revolutionizing diabetes management in India.
Category: pharma
Drug Approval Influence: The Wrong Way to Proceed
Drug approval influence is under scrutiny as Democratic Party’s Choi Jae-sung faces accusations of misconduct.
AstraZeneca stock reaction: Best Proven Gains After FDA Approval
AstraZeneca stock reaction shows significant gains following FDA’s accelerated approval for a new breast cancer treatment, boosting investor confidence.